BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 8744203)

  • 1. Soft-tissue uptake of Tc-99m DPD (dicarboxypropane diphosphonate) in amyloidosis.
    De Haro FJ; Castejon I; Besada E; Berrocal JO
    Clin Nucl Med; 1996 Jun; 21(6):509. PubMed ID: 8744203
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of cardiac scintigraphy with ⁹⁹mTc-DPD in the differentiation of cardiac amyloidosis subtype.
    de Haro-del Moral FJ; Sánchez-Lajusticia A; Gómez-Bueno M; García-Pavía P; Salas-Antón C; Segovia-Cubero J
    Rev Esp Cardiol (Engl Ed); 2012 May; 65(5):440-6. PubMed ID: 22464102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility and limitations of 3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy in systemic amyloidosis.
    Hutt DF; Quigley AM; Page J; Hall ML; Burniston M; Gopaul D; Lane T; Whelan CJ; Lachmann HJ; Gillmore JD; Hawkins PN; Wechalekar AD
    Eur Heart J Cardiovasc Imaging; 2014 Nov; 15(11):1289-98. PubMed ID: 24939945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of bone imaging with Tc-99m DPD and Tc-99m MDP: concise communication.
    Buell U; Kleinhans E; Zorn-Bopp E; Reuschel W; Muenzing W; Moser EA; Seiderer M
    J Nucl Med; 1982 Mar; 23(3):214-7. PubMed ID: 6460854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Etiology of amyloidosis determines myocardial 99mTc-DPD uptake in amyloidotic cardiomyopathy.
    Longhi S; Bonfiglioli R; Obici L; Gagliardi C; Milandri A; Lorenzini M; Guidalotti PL; Merlini G; Rapezzi C
    Clin Nucl Med; 2015 May; 40(5):446-7. PubMed ID: 25742226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 99mTc DPD is the preferential bone tracer for diagnosis of cardiac transthyretin amyloidosis.
    Rossi P; Tessonnier L; Frances Y; Mundler O; Granel B
    Clin Nucl Med; 2012 Aug; 37(8):e209-10. PubMed ID: 22785530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Technetium-99m MDP vs technetium-99m dicarboxypropane diphosphonate. A clinical comparison in various pathologic conditions.
    Godart G; Durez M; Bevilacqua M; Abramovici J; Robience Y
    Clin Nucl Med; 1986 Feb; 11(2):92-7. PubMed ID: 3769350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical studies on bone deposition of 99mTc-labeled-DPD (dicarboxypropane diphosphonate): a comparison with 99mTc-methylene diphosphonate].
    Otsuka N; Yoneda M; Sawai M; Saito J; Nagai K; Muranaka A; Terashima H; Yanagimoto S; Ito Y
    Kaku Igaku; 1982 Dec; 19(10):1573-8. PubMed ID: 6221135
    [No Abstract]   [Full Text] [Related]  

  • 9. Spleen visualization in both TTR and AL amyloidosis during
    Koutelou M; Tziomalos G; Chatzoglou V; Pappas N; Papanastasiou E; Chatzipavlidou V; Doumas A
    Hell J Nucl Med; 2023; 26(2):140-144. PubMed ID: 37527050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amyloidosis of heart and liver: comparison of Tc-99m pyrophosphate and Tc-99m methylene diphosphonate for detection.
    Lee VW; Caldarone AG; Falk RH; Rubinow A; Cohen AS
    Radiology; 1983 Jul; 148(1):239-42. PubMed ID: 6304810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New diphosphonate compounds for skeletal imaging: comparison with methylene diphosphonate.
    Subramanian G; McAfee JG; Thomas FD; Feld TA; Zapf-Longo C; Palladino E
    Radiology; 1983 Dec; 149(3):823-8. PubMed ID: 6316414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Noninvasive etiologic diagnosis of cardiac amyloidosis using 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy.
    Perugini E; Guidalotti PL; Salvi F; Cooke RM; Pettinato C; Riva L; Leone O; Farsad M; Ciliberti P; Bacchi-Reggiani L; Fallani F; Branzi A; Rapezzi C
    J Am Coll Cardiol; 2005 Sep; 46(6):1076-84. PubMed ID: 16168294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. (99m)Tc-DPD scintigraphy as a novel imaging modality for identification of skeletal muscle amyloid deposition in light-chain amyloidosis.
    Hutt DF; Gilbertson J; Quigley AM; Wechalekar AD
    Amyloid; 2016 Jun; 23(2):134-5. PubMed ID: 26981883
    [No Abstract]   [Full Text] [Related]  

  • 14. The impact of different bone tracers and acquisition times on image quality of equine bone scintigraphy.
    Mageed M; Dyab S; Swagemakers JH; Gerlach K
    Vet Radiol Ultrasound; 2022 Sep; 63(5):593-600. PubMed ID: 35666549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myocardial uptake of bone scintigraphic agents associated with increased pulmonary uptake.
    Bach-Gansmo T; Wien TN; Løndalen A; Halvorsen E
    Clin Physiol Funct Imaging; 2016 May; 36(3):237-41. PubMed ID: 25524030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tc-99m dicarboxypropane diphosphonate uptake in ovarian fibrothecoma.
    Danieli R; Moncliovic N; Pesce G; Reiner M; Bernier J
    Clin Nucl Med; 2000 Jun; 25(6):488-9. PubMed ID: 10836709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biokinetics of bone tracers by means of deconvolution analysis--comparison of 99mTc MDP, 99mTc DPD and 99mTc EHDP.
    Knop J; Stritzke P; Kröger E; Schneider C; Wasmus G
    Nuklearmedizin; 1982 Aug; 21(4):145-9. PubMed ID: 6216459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diagnosis of senile cardiac amyloidosis by (99m)Tc-DPD scintigraphy].
    Zannad N; Cosnay P; Guyetant S; May MA; Mohty D; Casset-Senon D
    Presse Med; 2009 Apr; 38(4):672-5. PubMed ID: 18922670
    [No Abstract]   [Full Text] [Related]  

  • 19. Usefulness and limitations of 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy in the aetiological diagnosis of amyloidotic cardiomyopathy.
    Rapezzi C; Quarta CC; Guidalotti PL; Longhi S; Pettinato C; Leone O; Ferlini A; Salvi F; Gallo P; Gagliardi C; Branzi A
    Eur J Nucl Med Mol Imaging; 2011 Mar; 38(3):470-8. PubMed ID: 21069320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic uptake of Tc-99m-labeled diphosphonate in amyloidosis: case report.
    Vanek JA; Cook SA; Bukowski RM
    J Nucl Med; 1977 Nov; 18(11):1086-8. PubMed ID: 72083
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.